Published in Malar J on March 25, 2012
The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam. Malar J (2015) 1.57
Outdoor malaria transmission in forested villages of Cambodia. Malar J (2013) 1.37
Serological measures of malaria transmission in Haiti: comparison of longitudinal and cross-sectional methods. PLoS One (2014) 1.14
Seasonal changes in the antibody responses against Plasmodium falciparum merozoite surface antigens in areas of differing malaria endemicity in Indonesia. Malar J (2013) 1.03
Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis. BMC Med (2014) 1.02
Serologically defined variations in malaria endemicity in Pará state, Brazil. PLoS One (2014) 1.02
Assessing malaria transmission in a low endemicity area of north-western Peru. Malar J (2013) 1.02
Hotspots of Malaria Transmission in the Peruvian Amazon: Rapid Assessment through a Parasitological and Serological Survey. PLoS One (2015) 0.98
Serology describes a profile of declining malaria transmission in Farafenni, The Gambia. Malar J (2015) 0.95
Research priorities for the development and implementation of serological tools for malaria surveillance. F1000Prime Rep (2014) 0.94
Genome-Scale Protein Microarray Comparison of Human Antibody Responses in Plasmodium vivax Relapse and Reinfection. Am J Trop Med Hyg (2015) 0.89
Current Mathematical Models for Analyzing Anti-Malarial Antibody Data with an Eye to Malaria Elimination and Eradication. J Immunol Res (2015) 0.84
Integration of Multiplex Bead Assays for Parasitic Diseases into a National, Population-Based Serosurvey of Women 15-39 Years of Age in Cambodia. PLoS Negl Trop Dis (2016) 0.84
Sample size and power calculations for detecting changes in malaria transmission using antibody seroconversion rate. Malar J (2015) 0.83
Plasmodium vivax malaria at households: spatial clustering and risk factors in a low endemicity urban area of the northwestern Peruvian coast. Malar J (2015) 0.83
Sero-epidemiological evaluation of Plasmodium falciparum malaria in Senegal. Malar J (2015) 0.80
Factors associated with high heterogeneity of malaria at fine spatial scale in the Western Kenyan highlands. Malar J (2016) 0.80
Geographical patterns of malaria transmission based on serological markers for falciparum and vivax malaria in Ratanakiri, Cambodia. Malar J (2016) 0.79
Serological markers to measure recent changes in malaria at population level in Cambodia. Malar J (2016) 0.78
High heterogeneity of malaria transmission and a large sub-patent and diverse reservoir of infection in Wusab As Safil district, Republic of Yemen. Malar J (2016) 0.78
Micro-epidemiological structuring of Plasmodium falciparum parasite populations in regions with varying transmission intensities in Africa. Wellcome Open Res (2017) 0.76
Multi-epitope chimeric antigen used as a serological marker to estimate Plasmodium falciparum transmission intensity in the border area of China-Myanmar. Infect Dis Poverty (2016) 0.75
Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand. Malar J (2017) 0.75
Serological measures to assess the efficacy of malaria control programme on Ambae Island, Vanuatu. Parasit Vectors (2017) 0.75
A longitudinal cohort study of malaria exposure and changing serostatus in a malaria endemic area of rural Tanzania. Malar J (2017) 0.75
The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg (2001) 11.74
Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A (2005) 6.39
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis (2009) 5.90
Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. J Infect Dis (2009) 5.73
Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis (2010) 3.86
Serology: a robust indicator of malaria transmission intensity? Trends Parasitol (2007) 3.63
Seroepidemiological evidence of eradication of malaria from Mauritius. Lancet (1973) 3.16
Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J (2008) 3.02
Malaria transmission and major malaria vectors in different geographical areas of Southeast Asia. Trop Med Int Health (2004) 2.98
Sub-microscopic malaria cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication for malaria elimination. Malar J (2010) 2.75
Large-scale malaria survey in Cambodia: novel insights on species distribution and risk factors. Malar J (2007) 2.75
Epidemiology of forest malaria in central Vietnam: a large scale cross-sectional survey. Malar J (2005) 2.67
Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis (2010) 2.59
IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J (2007) 2.30
Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea. PLoS One (2011) 2.18
The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol (2004) 2.16
The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. Trans R Soc Trop Med Hyg (1997) 2.12
Plasmodium vevax and P. falciparum: Biological interactions and the possibility of cross-species immunity. Parasitol Today (1997) 2.04
The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog (2010) 2.03
Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. Adv Parasitol (2009) 1.96
Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli. Clin Diagn Lab Immunol (1995) 1.92
Malaria in central Vietnam: analysis of risk factors by multivariate analysis and classification tree models. Malar J (2008) 1.79
Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting. Int Immunol (1996) 1.75
Sero-epidemiological surveillance of disappearing malaria in Greece. J Trop Med Hyg (1975) 1.58
False positive circumsporozoite protein ELISA: a challenge for the estimation of the entomological inoculation rate of malaria and for vector incrimination. Malar J (2011) 1.55
Ranking malaria risk factors to guide malaria control efforts in African highlands. PLoS One (2009) 1.38
Longevity of the immune response and memory to blood-stage malaria infection. Curr Top Microbiol Immunol (2005) 1.36
Longevity of naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1. Am J Trop Med Hyg (1999) 1.35
Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of Kenya. Infect Immun (2003) 1.29
Malaria transmission and vector behaviour in a forested malaria focus in central Vietnam and the implications for vector control. Malar J (2010) 1.26
The spatial and temporal patterns of falciparum and vivax malaria in Perú: 1994-2006. Malar J (2009) 1.25
Changing patterns of forest malaria among the mobile adult male population in Chumkiri District, Cambodia. Acta Trop (2008) 1.20
Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers. PLoS One (2011) 1.08
IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran. Acta Trop (2009) 0.99
Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya. Vaccine (2008) 0.98
Risk factors for malaria infection among ethnic minorities in Binh Phuoc, Vietnam. Southeast Asian J Trop Med Public Health (2009) 0.95
Seasonal fluctuation of antibody levels to Plasmodium falciparum parasitized red blood cell-associated antigens in two Senegalese villages with different transmission conditions. Am J Trop Med Hyg (2000) 0.93
Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria. Bull World Health Organ (1990) 0.83
Humoral immune responses against Plasmodium vivax MSP1 in humans living in a malaria endemic area in Flores, Indonesia. Southeast Asian J Trop Med Public Health (1998) 0.82
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Hyg (2006) 5.91
In vivo parasitological measures of artemisinin susceptibility. J Infect Dis (2010) 4.25
The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature (2004) 3.77
History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev (2004) 3.40
Behavioural heterogeneity of Anopheles species in ecologically different localities in Southeast Asia: a challenge for vector control. Trop Med Int Health (2005) 3.03
On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis (2010) 2.91
Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. BMJ (2009) 2.84
Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. Trans R Soc Trop Med Hyg (2006) 2.79
Epidemiology of forest malaria in central Vietnam: a large scale cross-sectional survey. Malar J (2005) 2.67
Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis (2007) 2.66
Malaria and urbanization in sub-Saharan Africa. Malar J (2005) 2.56
Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med (2007) 2.54
Four Artemisinin-Based Treatments in African Pregnant Women with Malaria. N Engl J Med (2016) 2.50
Pharmacovigilance of antimalarial treatment in Africa: is it possible? Malar J (2006) 2.48
Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy? Lancet Infect Dis (2009) 2.46
Reductions in malaria and anaemia case and death burden at hospitals following scale-up of malaria control in Zanzibar, 1999-2008. Malar J (2011) 2.45
The Anopheles dirus complex: spatial distribution and environmental drivers. Malar J (2007) 2.43
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS One (2009) 2.43
VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis. Dev Cell (2010) 2.37
Forest malaria in Vietnam: a challenge for control. Am J Trop Med Hyg (2004) 2.34
Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey. PLoS One (2011) 2.24
Detection of the East and West African kdr mutation in Anopheles gambiae and Anopheles arabiensis from Uganda using a new assay based on FRET/Melt Curve analysis. Malar J (2006) 2.22
A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax. Blood (2011) 2.17
Human Plasmodium knowlesi infections in young children in central Vietnam. Malar J (2009) 2.13
Multiple insecticide resistance: an impediment to insecticide-based malaria vector control program. PLoS One (2011) 2.07
Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis. PLoS One (2009) 2.05
Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. Infect Immun (2007) 2.01
Novel primer sequences for polymerase chain reaction-based detection of Trypanosoma brucei gambiense. Am J Trop Med Hyg (2002) 1.96
Spatial targeted vector control in the highlands of Burundi and its impact on malaria transmission. Malar J (2007) 1.93
Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family. Infect Immun (2002) 1.93
Spatial targeted vector control is able to reduce malaria prevalence in the highlands of Burundi. Am J Trop Med Hyg (2008) 1.88
The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg (2004) 1.86
Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis. Genes Dev (2007) 1.86
Analysis of the OspE determinants involved in binding of factor H and OspE-targeting antibodies elicited during Borrelia burgdorferi infection in mice. Infect Immun (2003) 1.86
Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing. Malar J (2008) 1.85
Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malar J (2009) 1.80
Malaria in central Vietnam: analysis of risk factors by multivariate analysis and classification tree models. Malar J (2008) 1.79
Selective regulation of arterial branching morphogenesis by synectin. Dev Cell (2006) 1.77
Trypanosoma brucei modifies the tsetse salivary composition, altering the fly feeding behavior that favors parasite transmission. PLoS Pathog (2010) 1.77
The serum resistance-associated gene as a diagnostic tool for the detection of Trypanosoma brucei rhodesiense. Am J Trop Med Hyg (2002) 1.76
Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Malar J (2008) 1.76
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J (2011) 1.73
A decline in the incidence of invasive non-typhoidal Salmonella infection in The Gambia temporally associated with a decline in malaria infection. PLoS One (2010) 1.72
Vector control in a malaria epidemic occurring within a complex emergency situation in Burundi: a case study. Malar J (2007) 1.66
Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements. PLoS One (2008) 1.65
A significant increase in kdr in Anopheles gambiae is associated with an intensive vector control intervention in Burundi highlands. Trop Med Int Health (2008) 1.63
Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence? Trop Med Int Health (2008) 1.63
Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial. PLoS Negl Trop Dis (2010) 1.61
Long-Lasting Insecticidal Hammocks for controlling forest malaria: a community-based trial in a rural area of central Vietnam. PLoS One (2009) 1.58
The insecticide resistance status of malaria vectors in the Mekong region. Malar J (2008) 1.56
Malaria in pregnancy: what can the social sciences contribute? PLoS Med (2007) 1.56
Can amodiaquine be used safely during pregnancy? Lancet Infect Dis (2004) 1.55
False positive circumsporozoite protein ELISA: a challenge for the estimation of the entomological inoculation rate of malaria and for vector incrimination. Malar J (2011) 1.55
Unexpected Rift Valley fever outbreak, northern Mauritania. Emerg Infect Dis (2011) 1.54
Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Lancet Infect Dis (2012) 1.53
Long-lasting insecticidal nets fail at household level to reduce abundance of sandfly vector Phlebotomus argentipes in treated houses in Bihar (India). Trop Med Int Health (2008) 1.51
Rapid decrease of malaria morbidity following the introduction of community-based monitoring in a rural area of central Vietnam. Malar J (2009) 1.51
Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. Malar J (2006) 1.50
Insecticide susceptibility of Phlebotomus argentipes in visceral leishmaniasis endemic districts in India and Nepal. PLoS Negl Trop Dis (2010) 1.50
Spatio-temporal patterns in kdr frequency in permethrin and DDT resistant Anopheles gambiae s.s. from Uganda. Am J Trop Med Hyg (2010) 1.49
Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design. J Infect Dis (2004) 1.48
Multilocus genotyping reveals high heterogeneity and strong local population structure of the Plasmodium vivax population in the Peruvian Amazon. Malar J (2010) 1.43
Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola. Trans R Soc Trop Med Hyg (2005) 1.40
An innovative tool for moving malaria PCR detection of parasite reservoir into the field. Malar J (2013) 1.40
Case management of severe malaria--a forgotten practice: experiences from health facilities in Uganda. PLoS One (2011) 1.39
Intensity of malaria transmission and the spread of Plasmodium falciparum resistant malaria: a review of epidemiologic field evidence. Am J Trop Med Hyg (2007) 1.39
An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso. Malar J (2012) 1.39
High complexity of Plasmodium vivax infections in symptomatic patients from a rural community in central Vietnam detected by microsatellite genotyping. Am J Trop Med Hyg (2010) 1.38
Ranking malaria risk factors to guide malaria control efforts in African highlands. PLoS One (2009) 1.38
Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children. Malar J (2011) 1.38
Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate. Am J Trop Med Hyg (2003) 1.38